Endocrinology, Vol 113, 657-662, Copyright © 1983 by Endocrine Society

ARTICLES

Glucocorticoids inhibit corticotropin-releasing factor-induced production of adenosine 3',5'-monophosphate in cultured anterior pituitary cells

LM Bilezikjian and WW Vale

The effect of corticotropin-releasing factor (CRF) on ACTH secretion and cAMP production by cultured anterior pituitary cells was investigated. Intracellular cAMP production was stimulated over 13-fold within 10 min in response to 10 nM CRF, reaching a plateau between 20 and 30 min. This was followed by a gradual decline in cellular cAMP, which was associated with its release into the medium. The release of both cAMP and ACTH followed similar time courses and remained linear over a 4-h incubation. CRF caused a dose-dependent increase in both cAMP production and ACTH release over a similar concentration range during short (30-min) incubations when cellular cAMP was maximal. During longer (4-h) incubations, however, significantly higher concentrations of CRF were required to stimulate cAMP production than those needed to stimulate ACTH release. Pretreatment of these cells with 20 nM dexamethasone for 18 h prevented CRF-stimulated ACTH secretion and significantly attenuated cAMP production at all time points during the 4 h. Concentrations of dexamethasone required to prevent CRF-stimulated ACTH release and cAMP production as well as 8- bromo-cAMP-stimulated ACTH release were similar. Equivalent results were obtained with corticosterone. These results suggest that changes in intracellular cAMP levels may, at least in part, mediate the action of CRF on ACTH secretion in the anterior pituitary gland and that one mechanism by which glucocorticoids exert their inhibitory action on corticotrophs may involve an effect on cAMP production.

This article has been cited by other articles:

				C. Porcher, A. Juhem, A. Peinnequin, V. Sinniger, and B. Bonaz Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1091 - G1103. [Abstract] [Full Text] [PDF]

				S. Ma, M. J. Shipston, D. Morilak, and J. A. Russell Reduced Hypothalamic Vasopressin Secretion Underlies Attenuated Adrenocorticotropin Stress Responses in Pregnant Rats Endocrinology, March 1, 2005; 146(3): 1626 - 1637. [Abstract] [Full Text] [PDF]

				P. J. Peeters, H. W. Gohlmann, I. Van den Wyngaert, S. M. Swagemakers, L. Bijnens, S. U. Kass, and T. Steckler Transcriptional Response to Corticotropin-Releasing Factor in AtT-20 Cells Mol. Pharmacol., November 1, 2004; 66(5): 1083 - 1092. [Abstract] [Full Text] [PDF]

				N. Bayatti, J. Zschocke, and C. Behl Brain Region-Specific Neuroprotective Action and Signaling of Corticotropin-Releasing Hormone in Primary Neurons Endocrinology, September 1, 2003; 144(9): 4051 - 4060. [Abstract] [Full Text] [PDF]

				B. Xu, T. Sano, S. Yamada, C. C. Li, and M. Hirokawa Expression of Corticotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Pituitary Corticotroph Adenomas Associated with Proliferative Potential J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1220 - 1225. [Abstract] [Full Text]

				C. J. Rossant, R. D. Pinnock, J. Hughes, M. D. Hall, and S. McNulty Corticotropin-Releasing Factor Type 1 and Type 2{alpha} Receptors Regulate Phosphorylation of Calcium/Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein and Activation of p42/p44 Mitogen-Activated Protein Kinase Endocrinology, April 1, 1999; 140(4): 1525 - 1536. [Abstract] [Full Text]

				J.-M. Aubry, A. V. Turnbull, G. Pozzoli, C. Rivier, and W. Vale Endotoxin Decreases Corticotropin-Releasing Factor Receptor 1 Messenger Ribonucleic Acid Levels in the Rat Pituitary Endocrinology, April 1, 1997; 138(4): 1621 - 1626. [Abstract] [Full Text] [PDF]